MENLO PARK, Calif.--(BUSINESS WIRE)--Optivia Biotechnology Inc., a leader in transporter sciences and in vitro transporter assay services, proudly announces that it has received the 2012 CRO Leadership Award from Life Science Leader Magazine, winning Productivity, Reliability, Regulatory and Accessibility award categories.
Life Science Leader Magazine based the awards upon extensive customer surveys and in-depth interviews of more than 2600 outsourcing-facing biopharmaceutical executives, that were independently conducted by Nice Insight on a quarterly basis to assess the relative qualities of over 100 CROs.
“Optivia is honored to receive this award as a validation of our leadership in the increasingly important field of Transporter Sciences,” said Yong Huang, Ph.D., president and Chief Executive Officer of Optivia Biotechnology, “Optivia has strived to deliver innovation, quality assay service and uncompromised customer support in meeting client needs. It is extremely gratifying that our efforts have been recognized by members of the biopharmaceutical industry we serve.”
“Optivia is the right company at the right time,” added Dominique Bridon, Ph.D., Executive Vice President and Chief Operating Officer of Optivia, “The field of transporter sciences is rapidly growing in light of increasing recognition of its utility in multiple aspects of drug discovery and development, especially in accessing drug-drug interactions (DDI) as evidenced by the recent FDA DDI Guidance (draft).”
“Optivia will continue to invest in innovation and business practice, delivering clients best-in-class assay services, value-added solution and remarkable client experience," Dr. Huang added.
About Transporter Sciences
Transporter sciences study membrane transporter proteins and their roles in (patho)physiology and pharmacology. Transporters are a class of 300 to 400 membrane proteins that act as nature’s “gatekeepers,” regulating trafficking of important endogenous substances and drugs in the body. As such, transporters not only play a vital role in drug response and safety, they can be pursued as therapeutic targets for various diseases.
About Optivia Biotechnology
Based in Menlo Park, CA, Optivia Biotechnology, Inc. is a leader in transporter research and transporter assay services. Optivia develops and provides an array of transporter assays, database and models to help in the discovery and development of drugs with improved safety and efficacy. For more information, visit www.optiviabio.com